Compare Abeona Therapeutics Inc (ABEO) vs Bank of Nova Scotia (BNS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Bank of Nova Scotia — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Bank of Nova Scotia trades at $84.88 (market cap $105.63B). The key difference: Bank of Nova Scotia is far larger — about 282.9× Abeona Therapeutics Inc's market cap, and Bank of Nova Scotia pays a 3.83% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | BNS | |
|---|---|---|
Market Cap | $373.32M | $105.63B |
Sector | Health | Financials |
52-Week High | $7.23 | $87.35 |
52-Week Low | $4.17 | $54.50 |
Enterprise Value | $228.22M | — |
Dividend Yield | — | 3.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →
